By: Shreeya Nanda From: medwirenews.com A phase 3 trial has demonstrated the noninferiority of two five-fraction adjuvant radiotherapy schedules delivered over a week to the standard 15-fraction schedule given over 3 weeks for early-stage breast cancer with regard to local control. The five-fraction regimen delivering 26 Gy of radiation, but not the one delivering 27 Gy, was also comparable to the standard of …